Skip to main content
    P

    Praxis Precision Medicines Inc (PRAX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $310.27
    -17.86 (-5.44%)

    Market Cap: $9.17B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Praxis Precision Medicines Inc (PRAX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Praxis Precision Medicines are Protagonist Therapeutics (PTGX), Spyre Therapeutics (SYRE) and PTC Therapeutics (PTCT). By market cap, Praxis Precision Medicines ranks 7th of the 13 companies on this page; Bio-Techne (TECH) is the largest at $11.44B. The median P/E of the 4 companies with a P/E is 40.0x.

    Peer Comparison

    PRAX's revenue growth of 1349.0% is above the peer median of 51.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Praxis Precision Medicines (PRAX)$9.17BN/AN/A0.0%N/A1349.0%0.00%
    Protagonist Therapeutics Inc (PTGX)$8.55B27.7x15.8x62.0%N/A5724.0%0.00%
    Spyre Therapeutics Inc. (SYRE)$9.88BN/AN/A0.0%N/A0.0%0.00%
    PTC Therapeutics Inc (PTCT)$5.30BN/A5.2x-9.2%18.1%69.6%0.00%
    Axsome Therapeutics Inc (AXSM)$7.45BN/A8.6x-18.2%-48.1%51.9%0.00%
    Krystal Biotech Inc (KRYS)$9.05B40.4x18.8x47.9%N/A30.2%0.00%
    Kymera Therapeutics Inc (KYMR)$10.89BN/A123.2x0.0%N/A466.4%0.00%
    Summit Therapeutics PLC (SMMT)$11.32BN/AN/A0.0%N/A-100.0%0.00%
    Madrigal Pharmaceuticals Inc (MDGL)$9.93BN/A8.7x-10.9%-12.7%50.1%0.00%
    Cogent Biosciences Inc (COGT)$4.97BN/AN/A0.0%-43.4%-100.0%0.00%
    TG Therapeutics Inc (TGTX)$9.75B87.2x11.1x11.8%11.0%60.7%0.00%
    Bio-Techne Corp (TECH)$11.44B39.6x9.3x14.0%7.7%4.6%0.44%
    Rhythm Pharmaceuticals Inc (RYTM)$7.97BN/A26.4x-69.0%-98.6%79.6%0.00%
    Peer median$9.40B40.0x11.1x0.0%-12.7%51.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Praxis Precision Medicines, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Protagonist Therapeutics Inc (PTGX)
    Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical...
    PTGX competitors
    Spyre Therapeutics Inc. (SYRE)
    Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by...
    SYRE competitors
    PTC Therapeutics Inc (PTCT)
    PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders.
    PTCT competitors
    Axsome Therapeutics Inc (AXSM)
    Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United...
    AXSM competitors
    Krystal Biotech Inc (KRYS)
    Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United...
    KRYS competitors
    Kymera Therapeutics Inc (KYMR)
    Kymera Therapeutics, Inc., a biopharmaceutical company, is focused on discovering and developing new small molecule treatments that selectively break down...
    KYMR competitors
    Summit Therapeutics PLC (SMMT)
    Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America...
    SMMT competitors
    Madrigal Pharmaceuticals Inc (MDGL)
    Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates...
    MDGL competitors
    Cogent Biosciences Inc (COGT)
    Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases.
    COGT competitors
    TG Therapeutics Inc (TGTX)
    TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development...
    TGTX competitors
    Bio-Techne Corp (TECH)
    Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments...
    TECH competitors
    Rhythm Pharmaceuticals Inc (RYTM)
    Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment...
    RYTM competitors

    Frequently Asked Questions About PRAX

    Who are Praxis Precision Medicines' main competitors?

    The companies most similar to Praxis Precision Medicines include Protagonist Therapeutics (PTGX), Spyre Therapeutics (SYRE), PTC Therapeutics (PTCT), Axsome Therapeutics (AXSM) and Krystal Biotech (KRYS), listed from the closest match.

    Who is Praxis Precision Medicines' biggest competitor?

    Bio-Techne (TECH) is the largest of the similar companies at $11.44B; Protagonist Therapeutics (PTGX) is the closest match by business profile, size, sector and industry.

    How does PRAX stock compare with its competitors?

    PRAX's net margin is 0.0% against a peer median of 0.0%.

    Which of Praxis Precision Medicines' competitors pays a higher dividend?

    Praxis Precision Medicines pays no dividend. Bio-Techne (TECH) has a higher forward dividend yield; Bio-Techne (TECH) has the highest at 0.44%.

    Is Praxis Precision Medicines bigger than its competitors?

    No. Praxis Precision Medicines is 7th by market cap among the 13 companies on this page; the largest is Bio-Techne (TECH) at $11.44B.